Carin Szostecki

2.5k total citations
18 papers, 1.5k citations indexed

About

Carin Szostecki is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Hepatology. According to data from OpenAlex, Carin Szostecki has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Immunology and 7 papers in Hepatology. Recurrent topics in Carin Szostecki's work include Liver Diseases and Immunity (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Retinoids in leukemia and cellular processes (5 papers). Carin Szostecki is often cited by papers focused on Liver Diseases and Immunity (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Retinoids in leukemia and cellular processes (5 papers). Carin Szostecki collaborates with scholars based in Germany, United States and Russia. Carin Szostecki's co-authors include Hans H. Guldner, Hans Will, Hans Netter, Helene Will, Thilo Grötzinger, Thomas Sternsdorf, A Viron, Marie-Claude Guillemin, Marcel Koken and Gustavo Linares‐Cruz and has published in prestigious journals such as The Journal of Experimental Medicine, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Carin Szostecki

16 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carin Szostecki Germany 14 917 400 396 319 282 18 1.5k
Hans H. Guldner Germany 15 634 0.7× 447 1.1× 485 1.2× 209 0.7× 240 0.9× 17 1.3k
Sophie Krieger France 19 633 0.7× 85 0.2× 521 1.3× 548 1.7× 119 0.4× 36 1.5k
Catherine Sibille Belgium 18 443 0.5× 577 1.4× 77 0.2× 141 0.4× 265 0.9× 30 1.3k
Ronald R. Nepomuceno United States 15 270 0.3× 454 1.1× 330 0.8× 60 0.2× 50 0.2× 20 1.1k
Christiane Werner‐Favre Switzerland 14 304 0.3× 1.1k 2.7× 108 0.3× 30 0.1× 263 0.9× 25 1.7k
Cinzia Mazza Italy 19 263 0.3× 479 1.2× 213 0.5× 129 0.4× 41 0.1× 44 1.2k
Sam Litwin United States 12 208 0.2× 514 1.3× 115 0.3× 81 0.3× 55 0.2× 26 945
Sara R. Selitsky United States 21 937 1.0× 470 1.2× 136 0.3× 143 0.4× 90 0.3× 45 1.9k
Mohammad Zafari United States 16 506 0.6× 1.5k 3.8× 102 0.3× 26 0.1× 255 0.9× 29 2.0k
G. G. de Lange Netherlands 16 380 0.4× 421 1.1× 88 0.2× 15 0.0× 147 0.5× 39 1.0k

Countries citing papers authored by Carin Szostecki

Since Specialization
Citations

This map shows the geographic impact of Carin Szostecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin Szostecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin Szostecki more than expected).

Fields of papers citing papers by Carin Szostecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carin Szostecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin Szostecki. The network helps show where Carin Szostecki may publish in the future.

Co-authorship network of co-authors of Carin Szostecki

This figure shows the co-authorship network connecting the top 25 collaborators of Carin Szostecki. A scholar is included among the top collaborators of Carin Szostecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carin Szostecki. Carin Szostecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Szostecki, Carin. (2016). MS — Vielfalt der Möglichkeiten nutzen. NeuroTransmitter. 27(4). 42–43. 1 indexed citations
2.
Szostecki, Carin. (2015). Noch mehr EVIDENCE. InFo Neurologie + Psychiatrie. 17(10). 63–63.
3.
Guldner, Hans H., et al.. (1999). Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. Journal of Cell Science. 112(5). 733–747. 51 indexed citations
4.
Szostecki, Carin, Hans H. Guldner, & Hans Will. (1997). Autoantibodies Against “Nuclear Dots” in Primary Biliary Cirrhosis. Seminars in Liver Disease. 17(1). 71–78. 67 indexed citations
5.
6.
Grötzinger, Thilo, Kirsten Jensen, Hans H. Guldner, et al.. (1996). A Highly Amplified Mouse Gene Is Homologous to the Human Interferon-Responsive Sp100 Gene Encoding an Autoantigen Associated with Nuclear Dots. Molecular and Cellular Biology. 16(3). 1150–1156. 21 indexed citations
7.
Sternsdorf, Thomas, Hans H. Guldner, Carin Szostecki, Thilo Grötzinger, & Hans Will. (1995). Two Nuclear Dot‐Associated Proteins, PML and SplOO, are Often Co‐Autoimmunogenic in Patients with Primary Biliary Cirrhosis. Scandinavian Journal of Immunology. 42(2). 257–268. 106 indexed citations
8.
Koken, Marcel, F Puvion-Dutilleul, Marie-Claude Guillemin, et al.. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.. The EMBO Journal. 13(5). 1073–1083. 422 indexed citations
9.
Szostecki, Carin, et al.. (1994). [Humoral autoimmune response to nuclear Sp100 autoantigen in patients with primary biliary cirrhosis].. PubMed. 88(7-8). 573–8. 1 indexed citations
10.
Guldner, Hans H., Carin Szostecki, Thilo Grötzinger, & Helene Will. (1992). IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. The Journal of Immunology. 149(12). 4067–4073. 142 indexed citations
11.
Szostecki, Carin, Hans Will, Hans Netter, & Hans H. Guldner. (1992). Autoantibodies to the Nuclear Sp100 Protein in Primary Biliary Cirrhosis and Associated Diseases: Epitope Specificity and Immunoglobulin Class Distribution. Scandinavian Journal of Immunology. 36(4). 555–564. 48 indexed citations
12.
Netter, Hans, Hans Will, Carin Szostecki, & Hans H. Guldner. (1991). Repetitive p68-autoantigen specific epitopes recognized by human anti-(U1) small nuclear ribonucleoprotein autoantibodies. Journal of Autoimmunity. 4(4). 651–663. 12 indexed citations
13.
Guldner, Hans H., Hans Netter, Carin Szostecki, E Jaeger, & Hans Will. (1990). Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus.. The Journal of Experimental Medicine. 171(3). 819–829. 52 indexed citations
14.
Szostecki, Carin, Hans H. Guldner, Hans Netter, & Helene Will. (1990). Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis.. The Journal of Immunology. 145(12). 4338–4347. 229 indexed citations
15.
Guldner, Hans H., Hans Netter, Carin Szostecki, H.‐J. Lakomek, & Hans Will. (1988). Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.. The Journal of Immunology. 141(2). 469–475. 70 indexed citations
16.
Netter, Hans, et al.. (1988). A recombinant autoantigen derived from the human (u1) small nuclear rnp‐specific 68‐kd protein. Arthritis & Rheumatism. 31(5). 616–622. 33 indexed citations
17.
Szostecki, Carin, et al.. (1987). Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100).. PubMed. 68(1). 108–16. 86 indexed citations
18.
Szostecki, Carin, et al.. (1986). Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma. 94(2). 132–138. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans H. Guldner Breakdown of academic impact, for papers by Sophie Krieger Breakdown of academic impact, for papers by Catherine Sibille Breakdown of academic impact, for papers by Ronald R. Nepomuceno Breakdown of academic impact, for papers by Christiane Werner‐Favre Breakdown of academic impact, for papers by Cinzia Mazza Breakdown of academic impact, for papers by Sam Litwin Breakdown of academic impact, for papers by Sara R. Selitsky Breakdown of academic impact, for papers by Mohammad Zafari Breakdown of academic impact, for papers by G. G. de Lange
Rankless by CCL
2026